WASHINGTON, Oct. 7, 2009 (GLOBE NEWSWIRE) -- Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Merix Corp. ("Merix" or the "Company") (Nasdaq:MERX) arising from the Company's announcement of its intent to merge with Viasystems Group, Inc. ("Viasystems").
Currently, Viasystems in a privately held corporation. Under the terms of the merger agreement, each Merix share will be converted into approximately 0.11 newly issued shares of Viasystems, subject to adjustment, which will be publicly traded on the NASDAQ upon completion of the transaction. No value has been put on the deal. Upon news of the merger, Merix's share price fell 81 cents -- over 29% -- to $1.95.
The investigation is focused on the potential unfairness of the consideration to Merix shareholders and the process by which the Merix Board of Directors is addressing the transaction.
If you are interested in discussing your rights as a Merix shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at contact@finkelsteinthompson.com.
Finkelstein Thompson LLP has spent over three decades delivering outstanding representation to institutional and individual clients in financial litigation, and has been appointed as lead or co-lead counsel in dozens of shareholder class actions. Indeed, the firm has served in leadership roles in cases that have recovered over $1 billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our web site at www.finkelsteinthompson.com. Attorney advertising. Prior results do not guarantee similar outcomes.